Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: A phase II study
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2010
At a glance
- Drugs Cisplatin; Doxorubicin; Gemcitabine
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2005 New trial record.